The project, which included UB’s Center for Integrated Global Biomedical Sciences, aims to keep hospitals and schools clean from viruses, microbial growth.
Waheed Adedeji will soon launch a clinical trial in Nigeria, exploring the pharmacokinetic interaction between the antidepressant fluoxetine and the antiviral drug Dolutegravir, which fights HIV.
John Violanti serves on the board of the Howard C. Liebengood Foundation, named for the Capitol police officer who died days after the Jan. 6, 2021, riot; has begun study looking at cancer among 9/11 first responders.
Study aims to fill a gap by investigating socio-economic, racial and ethnic disparities in children’s health and development from birth through the first year of life.